Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in Br J Pharmacol

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    July 2022
  1. KOHAJDA Z, Virag L, Hornyik T, Husti Z, et al
    In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
    Br J Pharmacol. 2022;179:3382-3402.
    PubMed     Abstract available


    June 2022
  2. CHAMPEROUX P, Fares R, Bastogne T, Richard S, et al
    Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
    Br J Pharmacol. 2022 Jun 24. doi: 10.1111/bph.15905.
    PubMed     Abstract available


  3. BANNISTER ML, MacLeod KT, George CH
    Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.
    Br J Pharmacol. 2022;179:2558-2563.
    PubMed     Abstract available


    May 2022
  4. HESKETH LM, Sikkel MB, Mahoney-Sanchez L, Mazzacuva F, et al
    OCT2013, an ischaemia-activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine.
    Br J Pharmacol. 2022;179:2037-2053.
    PubMed     Abstract available


    March 2022
  5. HORNYIK T, Rieder M, Castiglione A, Major P, et al
    Transgenic rabbit models for cardiac disease research.
    Br J Pharmacol. 2022;179:938-957.
    PubMed     Abstract available


  6. LOEN V, Vos MA, van der Heyden MAG
    The canine chronic atrioventricular block model in cardiovascular preclinical drug research.
    Br J Pharmacol. 2022;179:859-881.
    PubMed     Abstract available


    December 2021
  7. ROBINSON VM, Alsalahat I, Freeman S, Antzelevitch C, et al
    A Carvedilol Analogue, VK-II-86, Prevents Hypokalaemia-induced Ventricular Arrhythmia through Novel multi-Channel Effects.
    Br J Pharmacol. 2021 Dec 7. doi: 10.1111/bph.15775.
    PubMed     Abstract available


    November 2021
  8. SANDER P, Feng M, Schweitzer MK, Wilting F, et al
    Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca(2+) uptake and suppress cardiac arrhythmogenesis.
    Br J Pharmacol. 2021;178:4518-4532.
    PubMed     Abstract available


    February 2021
  9. SALJIC A, Jespersen T, Buhl R
    Antiarrhythmic investigations in large animal models of atrial fibrillation.
    Br J Pharmacol. 2021 Feb 24. doi: 10.1111/bph.15417.
    PubMed     Abstract available


    November 2020
  10. HUGHES DA
    Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.
    Br J Pharmacol. 2020;177:4975-4989.
    PubMed     Abstract available


    July 2020
  11. NI H, Iseppe AF, Giles WR, Narayan SM, et al
    Populations of in silico myocytes and tissues reveal synergy of multi-atrial-predominant K(+) -current block in atrial fibrillation.
    Br J Pharmacol. 2020 Jul 15. doi: 10.1111/bph.15198.
    PubMed     Abstract available


    May 2020
  12. FENNER MF, Carstensen H, Nissen SD, Hesselkilde EZ, et al
    Effect of Selective IK,ACh Inhibition by XAF-1407 in an Equine Model of Tachypacing-induced Persistent Atrial Fibrillation (AF).
    Br J Pharmacol. 2020 May 20. doi: 10.1111/bph.15100.
    PubMed     Abstract available


  13. HORNYIK T, Castiglione A, Franke G, Perez-Feliz S, et al
    Transgenic LQT2, LQT5 and LQT2-5 rabbit models with decreased repolarisation reserve for prediction of drug-induced ventricular arrhythmias.
    Br J Pharmacol. 2020 May 20. doi: 10.1111/bph.15098.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: